191 related articles for article (PubMed ID: 38473906)
1. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
[TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
[TBL] [Abstract][Full Text] [Related]
6. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
7. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
[TBL] [Abstract][Full Text] [Related]
8. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
9. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
10. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
11. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
[No Abstract] [Full Text] [Related]
12. Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1.
Ordas L; Costa L; Lozano A; Chevillard C; Calovoulos A; Kantar D; Fernandez L; Chauvin L; Dosset P; Doucet C; Heron-Milhavet L; Odintsova E; Berditchevski F; Milhiet PE; Bénistant C
Cells; 2021 Jun; 10(6):. PubMed ID: 34207462
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
17. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.
Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA
PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627
[TBL] [Abstract][Full Text] [Related]
19. p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma cells.
Chai J; Ju J; Zhang SW; Shen ZY; Liang L; Yang XM; Ma C; Ni QW; Sun MY
Oncol Rep; 2016 Aug; 36(2):737-44. PubMed ID: 27349208
[TBL] [Abstract][Full Text] [Related]
20. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
